|Multiple drug class-wide resistance associated with poorer survival after treatment failure in a cohort of HIV-infected patients|
M Zaccarelli, V Tozzi, P Lorenzini, MP Trotta, F Forbici, ...
Aids 19 (10), 1081-1089, 2005
|Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure|
F Ceccherini-Silberstein, F Erba, F Gago, A Bertoli, F Forbici, ...
Aids 18 (12), 11-19, 2004
|Novel human immunodeficiency virus type 1 protease mutations potentially involved in resistance to protease inhibitors|
V Svicher, F Ceccherini-Silberstein, F Erba, M Santoro, C Gori, ...
Antimicrobial agents and chemotherapy 49 (5), 2015-2025, 2005
|Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection|
V Svicher, V Cento, M Bernassola, M Neumann-Fraune, F Van Hemert, ...
Antiviral research 93 (1), 86-93, 2012
|Virologic correlates of adherence to antiretroviral medications and therapeutic failure.|
CF Perno, F Ceccherini-Silberstein, A De Luca, A Cozzi-Lepri, C Gori, ...
Journal of acquired immune deficiency syndromes (1999) 31, S118-22, 2002
|Reliability and clinical relevance of the HIV-1 drug resistance test in patients with low viremia levels|
MM Santoro, L Fabeni, D Armenia, C Alteri, D Di Pinto, F Forbici, A Bertoli, ...
Clinical infectious diseases 58 (8), 1156-1164, 2014
|Drug-class-wide resistance to antiretrovirals in HIV-infected patients failing therapy: prevalence, risk factors and virological outcome|
V Tozzi, M Zaccarelli, S Bonfigli, P Lorenzini, G Liuzzi, MP Trotta, F Forbici, ...
Antiviral therapy 11 (5), 553, 2006
|High sequence conservation of human immunodeficiency virus type 1 reverse transcriptase under drug pressure despite the continuous appearance of mutations|
F Ceccherini-Silberstein, F Gago, M Santoro, C Gori, V Svicher, ...
Journal of virology 79 (16), 10718-10729, 2005
|The profile of mutational clusters associated with lamivudine resistance can be constrained by HBV genotypes|
V Svicher, C Gori, M Trignetti, M Visca, V Micheli, M Bernassola, R Salpini, ...
Journal of hepatology 50 (3), 461-470, 2009
|Fast and sensitive quantitative detection of HIV DNA in whole blood leucocytes by SYBR green I real-time PCR assay|
A Casabianca, C Gori, C Orlandi, F Forbici, CF Perno, M Magnani
Molecular and cellular probes 21 (5-6), 368-378, 2007
|Role of hepatitis B virus genetic barrier in drug-resistance and immune-escape development|
V Svicher, V Cento, R Salpini, F Mercurio, M Fraune, B Beggel, Y Han, ...
Digestive and Liver Disease 43 (12), 975-983, 2011
|Subtype analysis and mutations to antiviral drugs in HIV‐1‐infected patients from Mozambique before initiation of antiretroviral therapy: Results from the DREAM programme|
MC Bellocchi, F Forbici, L Palombi, C Gori, E Coelho, V Svicher, ...
Journal of medical virology 76 (4), 452-458, 2005
|Impact of pre-therapy viral load on virological response to modern first-line HAART|
MM Santoro, D Armenia, C Alteri, P Flandre, A Calcagno, C Gori, L Fabeni, ...
International Medical Press 18 (7), 867-876, 2013
|Molecular diversity of HIV in Albania|
M Ciccozzi, C Gori, S Boros, MJ Ruiz-Alvarez, A Harxhi, M Dervishi, ...
The Journal of infectious diseases 192 (3), 475-479, 2005
|Q151M-mediated multinucleoside resistance: prevalence, risk factors, and response to salvage therapy|
M Zaccarelli, CF Perno, F Forbici, F Soldani, S Bonfigli, C Gori, MP Trotta, ...
Clinical infectious diseases 38 (3), 433-437, 2004
|Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients na´ve to the antiretroviral drugs|
C Alteri, V Svicher, C Gori, R D'Arrigo, M Ciccozzi, ...
BMC Infectious Diseases 9 (1), 1-11, 2009
|Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon|
J Fokam, R Salpini, MM Santoro, V Cento, R D’Arrigo, C Gori, CF Perno, ...
Archives of virology 156 (7), 1235-1243, 2011
|Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA study group|
C Alteri, M Montano, R D'Arrigo, M Andreoni, G Angarano, A Antinori, ...
Edizioni Internazionali 35 (1), 17-25, 2012
|Analysis of single-nucleotide polymorphisms (SNPs) in human CYP3A4 and CYP3A5 genes: potential implications for the metabolism of HIV drugs|
G Berno, M Zaccarelli, C Gori, M Tempestilli, A Antinori, CF Perno, ...
BMC medical genetics 15 (1), 1-7, 2014
|Using a database of HIV patients undergoing genotypic resistance test after HAART failure to understand the dynamics of M184V mutation|
M Zaccarelli, CF Perno, F Forbici, A Cingolani, G Liuzzi, A Bertoli, ...
Antiviral therapy 8 (1), 51-56, 2003